Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

499 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Gales AC, Jones RN, Sader HS. Gales AC, et al. Clin Microbiol Infect. 2006 Apr;12(4):315-21. doi: 10.1111/j.1469-0691.2005.01351.x. Clin Microbiol Infect. 2006. PMID: 16524407
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Sader HS, Erwin ME, Jones RN. Sader HS, et al. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):372-81. doi: 10.1007/BF01962081. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1327789
E test: a novel technique for antimicrobial susceptibility testing.
Sader HS, Pignatari AC. Sader HS, et al. Sao Paulo Med J. 1994 Oct-Dec;112(4):635-8. doi: 10.1590/s1516-31801994000400003. Sao Paulo Med J. 1994. PMID: 7481427 Review.
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
Jones RN, Sader HS, Erwin ME, Anderson SC. Jones RN, et al. Diagn Microbiol Infect Dis. 1995 Feb;21(2):85-93. doi: 10.1016/0732-8893(94)00147-o. Diagn Microbiol Infect Dis. 1995. PMID: 7628198 Clinical Trial.
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
Jones RN, Sader HS, Erwin ME. Jones RN, et al. Diagn Microbiol Infect Dis. 1994 Oct;20(2):93-8. doi: 10.1016/0732-8893(94)90098-1. Diagn Microbiol Infect Dis. 1994. PMID: 7867311 Clinical Trial.
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.
Sader HS, Pignatari AC, Frei R, Hollis RJ, Jones RN. Sader HS, et al. J Antimicrob Chemother. 1994 Mar;33(3):615-8. doi: 10.1093/jac/33.3.615. J Antimicrob Chemother. 1994. PMID: 7913704 No abstract available.
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
Sader HS, Jones RN, Allen SD, Gerlach EH, Murray PR, Washington JA. Sader HS, et al. J Chemother. 1993 Oct;5(5):283-8. doi: 10.1080/1120009x.1993.11739245. J Chemother. 1993. PMID: 8106899
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD, Erwin ME. Sader HS, et al. Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):143-50. doi: 10.1016/0732-8893(93)90025-3. Diagn Microbiol Infect Dis. 1993. PMID: 8243035 Clinical Trial.
499 results
Jump to page
Feedback